Biogen has been an ‘uninvestable’ stock for awhile, says Mizuho’s Jared Holz

June 14, 2023
Biogen has been an ‘uninvestable’ stock for awhile, says Mizuho’s Jared HolzBiogen has been an ‘uninvestable’ stock for awhile, says Mizuho’s Jared Holz

Jared Holz, Mizuho Securities healthcare sector specialist, joins ‘Fast Money’ to talk controversy brewing at Biogen, Alzheimer’s drug approval roadblocks in Europe, and more.

Share This

Latest Mizuho News

Mizuho Americas announces $1 million in grants through the Mizuho USA Foundation

Mizuho Americas announces $1 million in grants through the Mizuho USA Foundation

January 5, 2026
Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

November 18, 2025
VR has been ‘pretty big disappointment’ for Meta, says Mizuho’s Lloyd Walmsley

VR has been ‘pretty big disappointment’ for Meta, says Mizuho’s Lloyd Walmsley

December 4, 2025

Mizuho news from around the globe

back-to-top-blue